BUSINESS

Novartis to Acquire Myricx Bio for Up to $1.5 Billion

Novartis is buying UK biotech Myricx Bio for $1.1B upfront plus milestones, marking a major win for backer Sofinnova Partners.

BusinessWire
EDITOR'S PICKS

Markets

View all 6 →

Business

View all 6 →

Personal Finance

View all 3 →
MOST READ
  1. 1 BUSINESS

    Novartis to Acquire Myricx Bio for Up to $1.5 Billion

  2. 2 MARKETS

    Crypto Clarity Inches Forward as Congress Heads on Break

  3. 3 PERSONAL FINANCE

    Mortgage and Refinance Rates Jump Sharply This Week

  4. 4 MARKETS

    Peter Brandt Eyes Gold Over Bitcoin in Portfolio Shift

  5. 5 MARKETS

    Genesis Tables A$5.6B Binding Merger Bid for Vault Minerals

Stay informed.

One concise briefing, weekly. No spam.

By subscribing you agree to receive periodic communications. Unsubscribe anytime via the link in each message or our Unsubscribe page.